Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries

被引:0
|
作者
Evanthia Diamanti-Kandarakis
Christina Piperi
Efstratios Patsouris
Penelope Korkolopoulou
Dimitrios Panidis
Leszek Pawelczyk
Athanasios G. Papavassiliou
Antoni J. Duleba
机构
[1] University of Athens Medical School,First Department of Internal Medicine, Endocrine section
[2] University of Athens Medical School,Department of Biological Chemistry
[3] University of Athens Medical School,Department of Pathology
[4] Aristotle University of Thessaloniki,Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynaecology, Medical School
[5] Karol Marcinkowski University of Medical Sciences,Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obstetrics
[6] Yale University School of Medicine,Department of Obstetrics and Gynecology
来源
关键词
Advanced glycation end-products; NF-κB; Ovaries; PCOS; RAGE;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to investigate the localization/immunohistochemical distribution of AGEs and RAGE, as well as their putative signalling mediator NF-κB in ovaries of women with polycystic ovary syndrome (PCOS) compared to normal. Archival ovarian-tissue samples from biopsies of six women with PCOS and from six healthy of similar age women, were examined immunohistochemically with monoclonal anti-AGEs, anti-RAGE and anti-NF-κB(p50/p65) specific antibodies. In healthy women, AGE immunoreactivity was observed in follicular cell layers (granulosa and theca) and luteinized cells, but not in endothelial cells. PCOS specimens displayed AGE immunoexpression in theca interna and granulosa cells as well as in endothelial cells, but staining of granulosa cells was stronger than in that of normal ovaries. RAGE was highly expressed in normal and PCOS tissues. Normal tissue exhibited no staining differences between granulosa cell layer and theca interna. However, in PCOS ovaries, granulosa cells displayed stronger RAGE expression compared to theca interna cells in comparison to controls. NF-κB(p50/p65) was expressed in the cytoplasm of theca interna and granulosa cells of both normal and PCOS ovaries; whereas the NF-κB p65 subunit was only observed in granulosa cells nuclei in PCOS tissue. In conclusion, these findings demonstrate for the first time that RAGE and AGE-modified proteins with activated NF-κB are expressed in human ovarian tissue. Furthermore, a differential qualitative distribution of AGE, RAGE and NF-κB p65 subunit was observed in women with PCOS compared to healthy controls, where a stronger localization of both AGE and RAGE was observed in the granulosa cell layer of PCOS ovaries.
引用
收藏
页码:581 / 589
页数:8
相关论文
共 50 条
  • [31] ADVANCED GLYCATION END-PRODUCTS (AGES) INDUCE GLOMERULAR SCLEROSIS AND ALBUMINURIA IN NORMAL RATS
    VLASSARA, H
    STRIKER, LJ
    TEICHBERG, S
    FUH, H
    LI, YM
    STEFFES, M
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1995, 7 (33) : 69 - 71
  • [32] Lateral diffusion and signaling of receptor for advanced glycation end-products (RAGE): a receptor involved in chronic inflammation
    Syed, Aleem
    Zhu, Qiaochu
    Smith, Emily A.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2018, 47 (01): : 39 - 48
  • [33] Understanding RAGE, the receptor for advanced glycation end products
    Angelika Bierhaus
    Per M. Humpert
    Michael Morcos
    Thoralf Wendt
    Triantafyllos Chavakis
    Bernd Arnold
    David M. Stern
    Peter P. Nawroth
    Journal of Molecular Medicine, 2005, 83 : 876 - 886
  • [34] Serum levels of advanced glycation end-products (AGEs) in osteoporosis
    Lehmann, G
    Franke, S
    Wiegand, R
    Hein, G
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S259 - S259
  • [35] Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
    Scavello, Francesco
    Zeni, Filippo
    Tedesco, Calogero C.
    Mensa, Emanuela
    Veglia, Fabrizio
    Procopio, Antonio Domenico
    Bonfigli, Anna Rita
    Olivieri, Fabiola
    Raucci, Angela
    AGING-US, 2019, 11 (06): : 1648 - 1663
  • [36] Pathogenic role of advanced glycation end-products (AGEs): An overview
    Weiss, MF
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 : S47 - S52
  • [37] Receptor for Advanced Glycation End-products (RAGE) and CAC Progression in Adults with Type 1 Diabetes
    Brown, Talia L.
    Schmidt, Ann Marie
    Zhang, Jinqhua
    Kinney, Gregory L.
    Simpson, Melissa
    Rewers, Marian
    Snell-Bergeon, Janet K.
    CIRCULATION, 2011, 124 (21)
  • [38] Plasma Levels of Receptor for Advanced Glycation End-Products (RAGE) Are Associated with Primary Graft Dysfunction
    Christie, J. D.
    Shah, C. V.
    Kawut, S.
    Sonnett, J.
    Abya, V. N.
    Wille, K.
    Lama, V.
    Orens, J.
    Shah, A.
    Weinacker, A.
    Demissie, E.
    Bellamy, S.
    Ware, L. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S308 - S309
  • [39] Effects of Receptor for Advanced Glycation End-Products (RAGE) Signaling on Intestinal Ischemic Damage in Mice
    Makino, Yurika
    Munakata, Shinya
    Ueyama, Takae
    Honjo, Kumpei
    Kawano, Shingo
    Takahashi, Makoto
    Kojima, Yutaka
    Tomiki, Yuichi
    Sakamoto, Kazuhiro
    EUROPEAN SURGICAL RESEARCH, 2019, 60 (5-6) : 239 - 247
  • [40] ROLE OF OXYGEN IN FORMATION OF ADVANCED GLYCATION END-PRODUCTS (AGES)
    REDDY, S
    THORPE, SR
    BAYNES, JW
    FASEB JOURNAL, 1995, 9 (04): : A751 - A751